VISTAGEN THERAPEUTICS, INC. Other Expenses
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Other Expenses of $12.90 million for the 1-month period ending 2020-08-31, per its 10-Q filed 2021-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2021-08-12
- VISTAGEN THERAPEUTICS, INC. other expenses for the quarter ending 2014-12-31 was $134.90K.
| Period end | Other Expenses 1 month | Other Expenses 3 month | Other Expenses 9 month |
|---|---|---|---|
| 2020-08-31 | $12.90M 10-Q · filed 2021-08-12 | ||
| 2014-12-31 | $134.90K 10-Q · filed 2015-02-17 | $134.90K 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |